Latest News

Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen




Armenia, D; Di Carlo, D; Cozzi-Lepri, A; Calcagno, A; Borghi, V; Gori, C; Bertoli, A; … ICONA Foundation Study Group, ; + view all Armenia, D; Di Carlo, D; Cozzi-Lepri, A; Calcagno, A; Borghi, V; Gori, C; Bertoli, A; Gennari, W; Bellagamba, R; Castagna, A; Latini, A; Pinnetti, C; Cicalini, S; Saracino, A; Lapadula, G; Rusconi, S; Castelli, F; Di Giambenedetto, S; Andreoni, M; Di Perri, G; Antinori, A; Mussini, C; Ceccherini-Silberstein, F; Monforte, AD; Perno, CF; Santoro, MM; ICONA Foundation Study Group, ; – view fewer (2019) Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen. Antiviral Therapy 10.3851/IMP3309 . (In press). Green open access

Source link





Related posts

Are Scientific Journals Reliable? Study Exposes How Authors ‘Spin’ Abstracts

Newsemia

Opinion: Patients will be the losers as Pelosi’s plan to control drug prices nearly strikes out

Newsemia

Experimental antiplatelet compound for acute stroke shows promise

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy